ARTA
TCON

A.R.T. Advisors’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

A.R.T. Advisors’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-533
Closed -$25K – 1077
2019
Q4 		$25K Buy
+533
New +$35K ﹤0.01% 1277
2019
Q3 		– Sell
-129
Closed -$17K – 1785
2019
Q2 		$17K Buy
+129
New +$20.4K ﹤0.01% 1301

Other funds holding TCON

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return

A.R.T. Advisors's TCON Position: Q1 2020 in Review

A.R.T. Advisors sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q1 2020, closing a stake of 533 shares — an estimated $25K sold.

A.R.T. Advisors first reported a position in TCON in Q2 2019 and held it in 2 quarters. The position peaked at $25K in Q4 2019. 18 funds tracked by Wall St. Rank hold TCON as of Q1 2020.

  • A.R.T. Advisors reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 533 TRACON Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $25K.
  • A.R.T. Advisors first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
  • A.R.T. Advisors's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $25K in Q4 2019.
  • 18 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.